Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Higher incidence of perineal community acquired MRSA infections among toddlers.

McCullough AC, Seifried M, Zhao X, Haase J, Kabat WJ, Yogev R, Blumenthal RM, Mukundan D.

BMC Pediatr. 2011 Oct 27;11:96. doi: 10.1186/1471-2431-11-96.

2.

Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C.

Younossi ZM, McCullough AC, Barnes DS, Post A, Ong JP, O'Shea R, Martin LM, Bringman D, Farmer D, Levinthal G, Mullen KD, Carey WD, Tavill AS, Ferguson R, Gramlich T.

Dig Dis Sci. 2005 May;50(5):970-5.

PMID:
15906777
3.

Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C.

Younossi ZM, Mullen KD, Hodnick S, Barnes DS, Carey WD, McCullough AC, Easley K, Gramlich T, Liebermann BY.

J Clin Gastroenterol. 2003 May-Jun;36(5):427-30.

PMID:
12702987
4.

A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy.

Younossi ZM, Mullen KD, Zakko W, Hodnick S, Brand E, Barnes DS, Carey WD, McCullough AC, Easley K, Boparai N, Gramlich T.

J Hepatol. 2001 Jan;34(1):128-33.

PMID:
11211889
5.

New Stark regulations: Key issues for health care decision-makers.

Johnson BA, Niederman GA, Bowman LE, McCullough AC.

Med Group Manage J. 1998 Mar-Apr;45(2):10, 12-5, 50.

PMID:
10178589
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk